BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gutiérrez-González E, Cantero-Escribano JM, Redondo-Bravo L, San Juan-Sanz I, Robustillo-Rodela A, Cendejas-Bueno E, Influenza Working Group. Effect of vaccination, comorbidities and age on mortality and severe disease associated with influenza during the season 2016-2017 in a Spanish tertiary hospital. J Infect Public Health 2019;12:486-91. [PMID: 30670352 DOI: 10.1016/j.jiph.2018.11.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Aziz F, Aberer F, Moser O, Sourij C, von Lewinski D, Kaser S, Reichardt B, Sourij H. Impact of comorbidities on mortality in hospitalized influenza patients with diabetes - Analysis of the Austrian Health Insurance. Diabetes Res Clin Pract 2021;174:108758. [PMID: 33744375 DOI: 10.1016/j.diabres.2021.108758] [Reference Citation Analysis]
2 Brehm TT, van der Meirschen M, Hennigs A, Roedl K, Jarczak D, Wichmann D, Frings D, Nierhaus A, Oqueka T, Fiedler W, Christopeit M, Kraef C, Schultze A, Lütgehetmann M, Addo MM, Schmiedel S, Kluge S, Schulze Zur Wiesch J. Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza. Sci Rep 2021;11:5803. [PMID: 33707550 DOI: 10.1038/s41598-021-85081-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
3 Miatech JL, Tarte NN, Katragadda S, Polman J, Robichaux SB. A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana. Respir Med Case Rep 2020;31:101214. [PMID: 32923361 DOI: 10.1016/j.rmcr.2020.101214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Walzer P, Estève C, Barben J, Menu D, Cuenot C, Manckoundia P, Putot A. Impact of Influenza Vaccination on Mortality in the Oldest Old: A Propensity Score-Matched Cohort Study. Vaccines (Basel) 2020;8:E356. [PMID: 32635210 DOI: 10.3390/vaccines8030356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Yong SJ. Diseased lungs may hinder COVID-19 development: A possible reason for the low prevalence of COPD in COVID-19 patients. Med Hypotheses 2021;153:110628. [PMID: 34139599 DOI: 10.1016/j.mehy.2021.110628] [Reference Citation Analysis]
6 Harris GH, Rak KJ, Kahn JM, Angus DC, Mancing OR, Driessen J, Wallace DJ. US Hospital Capacity Managers' Experiences and Concerns Regarding Preparedness for Seasonal Influenza and Influenza-like Illness. JAMA Netw Open 2021;4:e212382. [PMID: 33739431 DOI: 10.1001/jamanetworkopen.2021.2382] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Van Goethem N, Robert A, Bossuyt N, Van Poelvoorde LAE, Quoilin S, De Keersmaecker SCJ, Devleesschauwer B, Thomas I, Vanneste K, Roosens NHC, Van Oyen H. Evaluation of the added value of viral genomic information for predicting severity of influenza infection. BMC Infect Dis 2021;21:785. [PMID: 34376182 DOI: 10.1186/s12879-021-06510-z] [Reference Citation Analysis]
8 Chang YC, Yu-Tung H, Chen LS, Tung HJ, Huang KH, Ernawaty E, Wu SY. Protective Effect of Seasonal Influenza Vaccination in Elderly Individuals with Disability in Taiwan: A Propensity Score-Matched, Nationwide, Population-Based Cohort Study. Vaccines (Basel) 2020;8:E140. [PMID: 32235779 DOI: 10.3390/vaccines8010140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Hasan MJ, Anam AM, Huq SMR, Rabbani R. Impact of Comorbidities on Clinical Outcome of Patients with COVID-19: Evidence from a Single-center in Bangladesh. Health Scope 2021;10. [DOI: 10.5812/jhealthscope.109268] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen J, Kelley WJ, Goldstein DR. Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19. J Immunol 2020;205:313-20. [PMID: 32493812 DOI: 10.4049/jimmunol.2000380] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
11 Hernández-Terán A, Garcíadiego-Fossas P, Villanueva-Reza M, Boukadida C, Taboada B, Porras E, Ahumada-Topete V, Tapia-Diaz KE, Matías-Florentino M, Pérez-García M, Ávila-Ríos S, Mejía-Nepomuceno F, Serna-Muñoz R, Juárez-Hernández F, Jiménez-Corona ME, Becerril-Vargas E, Barreto O, Martínez-Orozco JA, Pérez-Padilla R, Arias CF, Vázquez-Pérez JA. Clinical and Virological Features of Patients Hospitalized with Different Types of COVID-19 Vaccination in Mexico City. Vaccines (Basel) 2022;10:1181. [PMID: 35893830 DOI: 10.3390/vaccines10081181] [Reference Citation Analysis]
12 Bashir S, Moneeba S, Alghamdi A, Alghamdi F, Niaz A, Anan H, Kaleem I. Comorbidities in Patients with COVID-19 and Their Impact on the Severity of the Disease. Journal of Health and Allied Sciences NU 2021;11:01-7. [DOI: 10.1055/s-0040-1718848] [Reference Citation Analysis]
13 Jones RP, Ponomarenko A. Trends in Excess Winter Mortality (EWM) from 1900/01 to 2019/20-Evidence for a Complex System of Multiple Long-Term Trends. Int J Environ Res Public Health 2022;19:3407. [PMID: 35329098 DOI: 10.3390/ijerph19063407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
14 Brehm TT, van der Meirschen M, Hennigs A, Roedl K, Jarczak D, Wichmann D, Frings D, Nierhaus A, Oqueka T, Fiedler W, Christopeit M, Kraef C, Schultze A, Lütgehetmann M, Addo MM, Schmiedel S, Kluge S, Schulze Zur Wiesch J. Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza. Sci Rep 2021;11:5803. [PMID: 33707550 DOI: 10.1038/s41598-021-85081-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 16.0] [Reference Citation Analysis]
15 [DOI: 10.1101/2020.02.25.20027664] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Tennant E, Fletcher S, Kakar S, Najjar Z, Lord H, Clark P, Gupta L. Factors associated with adverse outcomes during influenza outbreaks in aged care facilities. Aust N Z J Public Health 2020;44:65-72. [PMID: 31617654 DOI: 10.1111/1753-6405.12933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Sharif N, Opu RR, Ahmed SN, Sarkar MK, Jaheen R, Daullah MU, Khan S, Mubin M, Rahman H, Islam F, Haque N, Islam S, Khan FB, Haque N, Ayman U, Shohael AM, Dey SK, Talukder AA. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave. Diabetes Metab Syndr 2021;15:102148. [PMID: 34186349 DOI: 10.1016/j.dsx.2021.05.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
18 Huemer F, Rinnerthaler G, Jörg B, Morre P, Stegbuchner B, Proksch E, Fleimisch S, Oberkofler H, Kremser I, Greil R, Egle A. Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 Registry. Geroscience 2021. [PMID: 33837912 DOI: 10.1007/s11357-021-00352-y] [Reference Citation Analysis]
19 Brehm TT, Heyer A, Roedl K, Jarczak D, Nierhaus A, Nentwich MF, van der Meirschen M, Schultze A, Christner M, Fiedler W, Kröger N, Huber TB, Klose H, Sterneck M, Jordan S, Kreuels B, Schmiedel S, Addo MM, Huber S, Lohse AW, Kluge S, Schulze Zur Wiesch J. Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020. J Clin Med 2021;10:2274. [PMID: 34073928 DOI: 10.3390/jcm10112274] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
20 Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX; China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020;55:2000547. [PMID: 32217650 DOI: 10.1183/13993003.00547-2020] [Cited by in Crossref: 1468] [Cited by in F6Publishing: 1] [Article Influence: 734.0] [Reference Citation Analysis]
21 Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX;  China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55. [PMID: 32217650 DOI: 10.1183/13993003.00547-2020] [Cited by in Crossref: 1258] [Cited by in F6Publishing: 1309] [Article Influence: 629.0] [Reference Citation Analysis]
22 Kashyap VK, Dhasmana A, Massey A, Kotnala S, Zafar N, Jaggi M, Yallapu MM, Chauhan SC. Smoking and COVID-19: Adding Fuel to the Flame. Int J Mol Sci 2020;21:E6581. [PMID: 32916821 DOI: 10.3390/ijms21186581] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
23 Soldevila N, Acosta L, Martínez A, Godoy P, Torner N, Rius C, Jané M, Domínguez A; Surveillance of Hospitalized Cases of Severe Influenza in Catalonia Working Group. Behavior of hospitalized severe influenza cases according to the outcome variable in Catalonia, Spain, during the 2017-2018 season. Sci Rep 2021;11:13587. [PMID: 34193898 DOI: 10.1038/s41598-021-92895-5] [Reference Citation Analysis]